Hydrolytic Properties of a Hybrid Xylanase and Its Parents

The hydrolytic properties of a hybrid xylanase (ATx) and its parents (reAnxA and reTfxA) were studied using xylans and xylooligosaccharides as substrates. Analysis of reaction mixtures by high-performance liquid chromatograph revealed that xylotriose (X3) was the main product released from birchwood xylan and wheat bran insoluble xylan by ATx and reAnxA, respectively. Xylobiose (X2) was the main product separately released from birchwood xylan and wheat bran insoluble xylan by reTfxA. Xylotetraose (X4), xylopentaose (X5), and xylohexaose (X6) could be hydrolyzed by ATx, which showed no activity on X2 and X3. Therefore, X4 might be the minimum oligomer hydrolyzed by ATx. X2–X6 could be hydrolyzed by reAnxA and reTfxA, respectively. All of ATx, reAnxA, and reTfxA showed transglycosylation activity.     

Hydrolytic and photochemical aging studies of a Kevlar-PBI blend

The focus of this work is the study of the hydrolytic and photochemical aging behavior of a Kevlar^®-PBI blend fabric. Tensile tests carried out on yarns extracted from this fabric after either irradiation with UV light or exposure to high humidity indicated a continuous decrease of the breaking force with exposure time. ATR-FTIR analyses of photo-chemically aged samples showed evidence of a photo-oxidative reaction initiated by the cleavage of the amide bond of Kevlar. The overlapping of the breaking-force curves that was observed as the irradiance level was increased at constant temperature is believed to be caused by a “screen” effect produced by Photo-Fries products. The fact that at constant temperature the breaking force was unaffected by the variation of the relative humidity suggests that the absorption of water is not the rate-controlling step in the degradation kinetics. ATR-FTIR analyses revealed the presence of a new absorption band ascribed to carboxylic acid end groups produced during the hydrolysis of the amide linkage that occurred after humidity aging. The relative intensity of the -COOH band tended to a constant value as exposure times increased, suggesting that in addition to the hydrolysis, a competing recombination reaction takes place during degradation. A kinetic model for the hydrolytic degradation process was formulated and solved.     

Alkaline Hydrolytic Pathway of the Antitumor Drug,Cyclophosphamide

Abstract

In an attempt to clarify the alkaline hydrolytic pathway of the antitumor agent, cyclophosphamide (CP), the time course of its degradation was monitored by ³¹P NMR in 0.5 M KOH solution. After 16 hr at 25°C. 70% of CP is hydrolyzed (t_½ 9 hr) leading to a mixture of 8 phosphorated compounds. among them only 4 represented more than 5% of the initial CP. The chemical shifts and the intensities of these compounds were as follows: 1 1 .1 ppm. 30% of the initial CP (compound 1); 9.5 ppm, 12% (compound 2); 6.4 ppm, 9% (unknown) and 4.8 ppm, 9% (compound 3). The structures of compounds 1–3 were identified by NMR (13C and IH) and mass spectrometry after their isolation. The major degradation compound formed, the nine-membered ring compound I, was also observed during CP hydrolysis at neutral or moderately acid pHsill and was detected in urine of patients treated with CP[2] Compounds 2 and 3 were also formed during the hydrolysis of compound I in 0.5 M KOH solution. Based on the formation in time of the 31P NMR signals in KOH solutions of CP and compound I, the following scheme was established for the major degradation alkaline pathway of CP.     

Hydrolytic degradation of POSS-PEG-lactide hybrid hydrogels

A polyhedral oligomeric silsesquioxane (POSS), functionalized with eight arms of poly(ethylene glycol) (PEG; MW 400) and then acrylated, was incorporated into a hydrogel network based on triblock copolymers of poly(lactide-b-ethylene glycol-b-lactide) diacrylates using a redox-initiated polymerization. The organic-inorganic hybrid hydrogels so prepared contained the inorganic crosslinker POSS from 1 to 28 wt.%. The degradation properties of the hydrogels in a pH 7.4 phosphate-buffered saline solution at 37 °C were studied using measurements of mass loss, cryogenic SEM, and ATR-FTIR spectroscopy. It was found that copolymerization of acrylated 1kPEG-lactide with increasing amounts of POSS created a more porous network which was more resistant to hydrolysis. The ATR-FTIR technique was used to monitor the progress of degradation with exposure time through the changes in the carbonyl and C-H deformation bands of the lactide and the Si-C stretching band of the POSS. Increasing POSS incorporation resulted in decreased rate of degradation due to its hydrophobic nature and inertness to hydrolysis. Conversely, an increase in lactide content increased the degradation rate due to the increased number of hydrolytically-sensitive ester groups in the network.     

Hydrolytic stability of oligoesters: comparison of steric with anchimeric effects

A comparison of steric and anchimeric effects on the hydrolytic stability of polyesters was studied. Twelve monomers were selected based on their propensity toward steric and anchimeric interactions: adipic acid, isophthalic acid, phthalic anhydride, hexahydrophthalic anhydride, 1,4-cyclohexanedicarboxylic acid, maleic anhydride, ethylene glycol, 1,2-propanediol, 1,3-propanediol 1,4-butanediol, 1,5-pentanediol, and neopentyl glycol. Hydroxyl terminated oligoesters consisting of one diacid and one diol and one hydroxyl terminated oligoester consisting of two diacids and one diol were prepared. The hydrolytic stability was evaluated in an acetone/water solution. The acid number was monitored as a function of time. It was found that telechelic groups favor anchimeric interactions, while steric groups determine the rate of hydrolysis for the main chain.     

含有一个非平面杂环胺配体的新型反铂抗癌药物的水解机理

用B3LYP杂化泛函和等电子聚焦极化连续模型(IEF-PCM)研究了trans-[PtCl2(NH3)(Am)](Am: 非平面哌啶或哌嗪)新型反铂抗癌药物的水解反应机理. 对经由一般的SN2机理的第一步和第二步水解反应势能面上的稳定点进行了全优化和表征. 在水解中, 最显著的结构变化发生在反应过渡态和中间体的五配位三角双锥的赤道面上. 与经典顺铂(cisplatin)比较, 反式[PtCl2(NH3)(piperazine)]的第一步和第二步水解活化能均低于顺铂, 而反式[PtCl2(NH3)(piperidine)]的第一步水解活化能稍高于顺铂, 第二步水解活化能稍低于顺铂. 计算表明, 这些含有非平面杂环胺反铂的配合物减小了赤道面上的立体效应和水解势垒.     

Synthesis of Carvacrol Derivatives as Potential New Anticancer Agent against Lung Cancer

Lung cancer remains a major public health concern among all cancer diseases due to the toxicity and side-effects of the available commercially synthesized drugs. Natural product-derived synthesized anticancer drugs are now of promising interest to fight against cancer death. Carvacrol is a major component of most essential oil-bearing plants with potential pharmacological activity, especially against various cancer cell lines. Among the other organometallic compounds, copper complexes have been reported to be effective anticancer agents against various cancer cell lines, especially lung and leukemia cancers, due to the nontoxic nature of copper in normal cells since it is an endogenic metal. In this study, we synthesized three carvacrol derivatives, i.e., carvacrol aldehyde, Schiff base, and copper–Schiff base complex, through an established synthesis protocol and characterized the synthesized product using various spectroscopic techniques. The synthesized derivatives were evaluated for in vitro cytotoxic activity against different cancer cell lines, including human lung cancer (A549) and human fibroblast (BALB-3T3). Our findings showed that the copper–Schiff base complex derived from carvacrol inhibited the proliferation and migration of the A549 cell lines in a dose-dependent manner. This activity might be due to the inhibition of cell proliferation and migration at the G₂/M cell-cycle phase, as well as apoptosis, possibly through the activation of the mitochondrial apoptotic pathway. To our knowledge, this is the first report on the activity of the copper–Schiff base complex of carvacrol against A549 cell lines. Our result highlights that a new synthesized copper complex from carvacrol could be a novel potential drug in the treatment of lung cancer.     

氨硼烷水解制氢的研究进展

介绍一种很有潜力的储氢材料——氨硼烷的合成及水解.重点讨论近几年氨硼烷水解的催化剂,并对催化剂的载体进行了介绍.     

Hydrolytic degradation and functional stability of a segmented shape memory poly(ester urethane)

In order to understand the effects of water and hydrolytic ageing on semi-crystalline poly(ester urethane) and its shape memory functionality, water immersion experiments at elevated temperature have been performed on a model substance and various parameters were monitored: change of the melting/crystallisation temperatures, substantial increase in crystallinity, temperature dependence of the water diffusion coefficient and solubility, hydrogen-bonding index and phase mixing by peak deconvolution of the FT-IR carbonyl region and day-to-day tensile and thermo-mechanical cyclic tensile tests. A rising fraction of freezable water agglomerates in the polymer was found for specimens cooled from the immersion temperature. The degradation process could be divided into three phases: an induction phase, a phase of continuous degradation and a phase of accelerated degradation. Shape recovery remains fairly constant during phase one and decreases slowly during phase two. The increase in crystallinity in phase two is accompanied by an increase in shape fixing ability.     

聚苯乙烯—吡啶树脂的合成及催化水解反应

在氢氧化钠作用下，氯甲基化聚苯乙烯与吡啶反应制成聚苯乙烯－吡啶树脂，测定了其化学组成和红外光谱，并考察了在酯水解反应中的催化活性。     

Hydrolytic cleavage of DNA by quercetin manganese(II) complexes

Quercetin manganese(II) complexes were investigated focusing on its DNA hydrolytic activity. The complexes successfully promote the cleavage of plasmid DNA, producing single and double DNA strand breaks. The amount of conversion of supercoiled form (SC) of plasmid DNA to the nicked circular form (NC) depends on the concentration of the complex as well as the duration of incubation of the complexes with DNA. The maximum rate of conversion of the supercoiled form to the nicked circular form at pH 7.2 in the presence of 100 μM of the complexes is found to be 1.32 × 10⁻⁴ s⁻¹. The hydrolytic cleavage of DNA by the complexes was supported by the evidence from free radical quenching, thiobarbituric acid-reactive substances (TBARS) assay and T4 ligase ligation.     

A Maltol-Containing Ruthenium Polypyridyl Complex as a Potential Anticancer Agent

Cancer is one of the main causes of death worldwide. Chemotherapy, despite its severe side effects, is to date one of the leading strategies against cancer. Metal-based drugs present several potential advantages when compared to organic compounds and they have gained trust from the scientific community after the approval on the market of the drug cisplatin. Recently, we reported the ruthenium complex ([Ru(DIP)₂(sq)](PF₆) (where DIP is 4,7-diphenyl-1,10-phenantroline and sq is semiquinonate) with a remarkable potential as chemotherapeutic agent against cancer, both in vitro and in vivo. In this work, we analyse a structurally similar compound, namely [Ru(DIP)₂(mal)](PF₆), carrying the flavour-enhancing agent approved by the FDA, maltol (mal). To possess an FDA approved ligand is crucial for a complex, whose mechanism of action might include ligand exchange. Herein, we describe the synthesis and characterisation of [Ru(DIP)₂(mal)](PF₆), its stability in solutions and under conditions that resemble the physiological ones, and its in-depth biological investigation. Cytotoxicity tests on different cell lines in 2D model and on HeLa MultiCellular Tumour Spheroids (MCTS) demonstrated that our compound has higher activity than cisplatin, inspiring further tests. [Ru(DIP)₂(mal)](PF₆) was efficiently internalised by HeLa cells through a passive transport mechanism and severely affected the mitochondrial metabolism.     

Berberine as a Potential Anticancer Agent: A Comprehensive Review

Berberine (BBR), a potential bioactive agent, has remarkable health benefits. A substantial amount of research has been conducted to date to establish the anticancer potential of BBR. The present review consolidates salient information concerning the promising anticancer activity of this compound. The therapeutic efficacy of BBR has been reported in several studies regarding colon, breast, pancreatic, liver, oral, bone, cutaneous, prostate, intestine, and thyroid cancers. BBR prevents cancer cell proliferation by inducing apoptosis and controlling the cell cycle as well as autophagy. BBR also hinders tumor cell invasion and metastasis by down-regulating metastasis-related proteins. Moreover, BBR is also beneficial in the early stages of cancer development by lowering epithelial–mesenchymal transition protein expression. Despite its significance as a potentially promising drug candidate, there are currently no pure berberine preparations approved to treat specific ailments. Hence, this review highlights our current comprehensive knowledge of sources, extraction methods, pharmacokinetic, and pharmacodynamic profiles of berberine, as well as the proposed mechanisms of action associated with its anticancer potential. The information presented here will help provide a baseline for researchers, scientists, and drug developers regarding the use of berberine as a promising candidate in treating different types of cancers.     

Hydrolytic Methods for the Quantification of Fructose Equivalents in Herbaceous Biomass

A low, but significant, fraction of the carbohydrate portion of herbaceous biomass may be composed of fructose/fructosyl-containing components (“fructose equivalents”); such carbohydrates include sucrose, fructooligosaccharides, and fructans. Standard methods used for the quantification of structural-carbohydrate-derived neutral monosaccharide equivalents in biomass are not particularly well suited for the quantification of fructose equivalents due to the inherent instability of fructose in conditions commonly used for hemicellulose/cellulose hydrolysis (>80% degradation of fructose standards treated at 4% sulfuric acid, 121°C, 1 h). Alternative time, temperature, and acid concentration combinations for fructan hydrolysis were considered using model fructans (inulin, β-2,1, and levan, β-2,6) and a grass seed straw (tall fescue, Festuca arundinacea) as representative feedstocks. The instability of fructose, relative to glucose and xylose, at higher acid/temperature combinations is demonstrated, all rates of fructose degradation being acid and temperature dependent. Fructans are shown to be completely hydrolyzed at acid concentrations well below that used for the structural carbohydrates, as low as 0.2%, at 121°C for 1 h. Lower temperatures are also shown to be effective, with corresponding adjustments in acid concentration and time. Thus, fructans can be effectively hydrolyzed under conditions where fructose degradation is maintained below 10%. Hydrolysis of the β-2,1 fructans at temperatures ≥50°C, at all conditions consistent with complete hydrolysis, appears to generate difructose dianhydrides. These same compounds were not detected upon hydrolysis of levan, sucrose, or straw components. It is suggested that fructan hydrolysis conditions be chosen such that hydrolysis goes to completion; fructose degradation is minimized, and difructose dianhydride production is accounted for.     

薄层层析法测定纤维素材料水解液中混合糖的研究

提出了用薄层层析测定纤维素材料水解液混合糖中单糖和各种多糖的含量，以硅胶G为固体吸附剂，以玻璃为支撑物，制成薄层析。以V正丁醇：V37％乙酸：V水＝3：2：2为展开剂，以苯胺－草酸为显色剂，分离效果良好，可完成定性和定量分析任务。     

Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight

Cancer is a serious disease with high mortality and morbidity worldwide. Natural products have served as a major source for developing new anticancer drugs during recent decades. Magnolol, a representative natural phenolic lignan isolated from Magnolia officinali, has attracted considerable attention for its anticancer properties in recent years. Accumulating preclinical studies have demonstrated the tremendous therapeutic potential of magnolol via a wide range of pharmacological mechanisms against cancer. In this review, we summarized the latest advances in preclinical studies investigating anticancer properties of magnolol and described the important signaling pathways explaining its underlying mechanisms. Magnolol was capable of inhibiting cancer growth and metastasis against various cancer types. Magnolol exerted anticancer effects through inhibiting proliferation, inducing cell cycle arrest, provoking apoptosis, restraining migration and invasion, and suppressing angiogenesis. Multiple signaling pathways were also involved in the pharmacological actions of magnolol against cancer, such as PI3K/Akt/mTOR signaling, MAPK signaling and NF-κB signaling. Based on this existing evidence summarized in the review, we have conclusively confirmed magnolol had a multi-target anticancer effect against heterogeneous cancer disease. It is promising to develop magnolol as a drug candidate for cancer therapy in the future.